Application of mRNA Vaccines in Head and Neck Cancer Immunotherapy: Current Progress and Challenges.
Head and neck cancer (HNC) remains a significant global health burden, with high morbidity and mortality despite advances in conventional therapies. The immunosuppressive tumor microenvironment (TME) and tumor heterogeneity have limited the efficacy of current treatments, driving the exploration of novel immunotherapeu...